You may have heard that scientists are on the threshold of developing nanomachines which will perform reconstructive procedures at the cellular level…. and are just step away from creating the tools to cure cancer.
Take it from me: invest in this exciting “opportunity” and you will soon need a cure for your plummeting brokerage account balance!
You must tread carefully through today’s minefield of explosive nano announcements. There are real advancements and then there are conceptual goals. Separating the one from the other is the difference between making money or losing money.
However, there is a real company with groundbreaking developments that you can invest in with confidence.
This up-and-coming nanotech company has a microbocide that prevents the spread of sexually transmitted diseases, including HIV and genital herpes. Durex has signed a co-development deal to use this gel as a spermicide on their condoms, ensuring a steady stream of future business for this nano company.
Find out from our scientific panel which nanotech stocks have genuine profit-potential.
Nanotech Investing News is devoted to making sure its readers don't fall for 'The Next Big Thing' hype. With contributions from some of the nation's top financial analysts and the world’s premier science journal New Scientist, it keeps you abreast of who is doing what on nano’s cutting edge.
Cientifica, the world’s largest nanotech consultancy company recently projected that the total market for nanotechnology-enabled drug delivery will rise to $220 billion by 2015 from $3 billion today. That’s a compounded annual growth rate of 59%.
About 1,500 companies worldwide have announced nanotechnology research plans. Sales of nanotech products have already increased 2037% in the past two years!
Google states that over a million people click on nanotechnology sites every week. While most of these folks chase the hoopla about nanotechnology, you can get solid information on the few companies that will make a difference.
Just enter your e-mail address in the box at the top right of the page and click "Subscribe" to begin your FREE bi-weekly advisory, and see how to profit from the industrial revolution of the 21st century.
Extra Bonus - when you sign up for Nanotech Investing News you will also get a copy of my special free report, Nanotech Medical Miracle – a detailed debriefing on which medical companies are making genuine profit-generating advances.
GS Early
Editor, Nanotech Investing News
PS. In Nanotech Medical Miracle you’ll see other phenomenal opportunities similar to the company with the breakthrough advancements against HIV. Like the undervalued world class pharmaceutical company that has developed carbon nanotubes for propriety drug delivery and another that uses nanotechnology to prevent stents from being attacked by the immune system. This and so much more is all in my free report Nanotech Medical Miracle when you sign up for Nanotech Investing News.

Gregg Early is vice-president of KCI Communications and executive editor of Personal Finance. He’s also editor of The Real Nanotech Investor, a financial advisory on the nascent sector of nanotech and distech (disruptive technology), and Nanotech Investing News, a free e-zine that provides regular updates on developments in high tech.
| GS EARLY - BIO | ARCHIVES Executive Editor: Personal Finance Editor: New Tech Investor |
| ELLIOTT GUE - BIO | ARCHIVES Editor: Personal Finance, The Energy Strategist, The Energy Letter |
| ROGER CONRAD - BIO | ARCHIVES Top 3 Dividend StocksEditor: Canadian Edge, Utility Forecaster, Maple Leaf Memo, Utility & Income |
| YIANNIS MOSTROUS - BIO | ARCHIVES Editor: Silk Road Investor, Emerging Markets Speculator |
| GEORGE KLEINMAN - BIO | ARCHIVES Editor: Futures Market Forecaster, Commodities Trends |
![]() | DAVID DITTMAN - BIO | ARCHIVES Editor: Maple Leaf Memo |
![]() | BEN SHEPHERD - BIO | ARCHIVES Free Stock Market Tips Editor: Louis Rukeyser's Wall Street, Louis Rukeyser's Mutual Funds, Friday Market Wrapup |
![]() | HANK HEYMING - ARTICLES |
![]() | BOB CARLSON - ARTICLES |